Literature DB >> 22759941

Associations among metacognitive beliefs, anxiety and positive schizotypy during adolescence.

Martin Debbané1, Martial Van der Linden, Dario Balanzin, Joël Billieux, Stephan Eliez.   

Abstract

The expression of early delusion and hallucination-like symptoms, known as positive schizotypy (PS), holds predictive power for later development of psychotic disorders. However, little is known about the psychological and emotional processes promoting the expression of PS during adolescent development. Our study's objective was to examine the nature of the relationships between adolescent PS and two dimensions previously identified to contribute to adult positive symptoms of psychosis, metacognitive beliefs and anxiety. Using a structural equation modeling design, data from self-report questionnaires measuring anxiety, metacognitive beliefs, and PS were collected from 179 adolescents aged 12 to 19 years. Our results indicate that although metacognitive beliefs significantly influence adolescent PS and anxiety, maladaptive contradictory metacognitive beliefs specifically potentiate positive schizotypal expression in hallucination-prone adolescents. Furthermore, we observe that PS and anxiety entertain reciprocal relationships. These findings suggest that relationships between metacognitive beliefs, anxiety, and PS can already be observed during adolescence.

Entities:  

Mesh:

Year:  2012        PMID: 22759941     DOI: 10.1097/NMD.0b013e31825bfc1a

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  8 in total

1.  Strange-face-in-the-mirror illusion and schizotypy during adolescence.

Authors:  Eduardo Fonseca-Pedrero; Deborah Badoud; Lia Antico; Giovanni B Caputo; Stephan Eliez; Sophie Schwartz; Martin Debbané
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

2.  A comprehensive review of auditory verbal hallucinations: lifetime prevalence, correlates and mechanisms in healthy and clinical individuals.

Authors:  Saskia de Leede-Smith; Emma Barkus
Journal:  Front Hum Neurosci       Date:  2013-07-16       Impact factor: 3.169

3.  Hallucinations in Children and Adolescents: An Updated Review and Practical Recommendations for Clinicians.

Authors:  Kim Maijer; Mark Hayward; Charles Fernyhough; Monica E Calkins; Martin Debbané; Renaud Jardri; Ian Kelleher; Andrea Raballo; Aikaterini Rammou; James G Scott; Ann K Shinn; Laura A Steenhuis; Daniel H Wolf; Agna A Bartels-Velthuis
Journal:  Schizophr Bull       Date:  2019-02-01       Impact factor: 9.306

4.  Validation of the French version of the « Meta-Cognition Questionnaire » for adolescents (MCQ-Af): Evolution of metacognitive beliefs with age and their links with anxiety during adolescence.

Authors:  Yasmina Lachat Shakeshaft; Thierry Lecerf; Larisa Morosan; Deborah Myriam Badoud; Martin Debbané
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

5.  Attachment and problematic Facebook use in adolescents: The mediating role of metacognitions.

Authors:  Claudia Marino; Tatiana Marci; Lucrezia Ferrante; Gianmarco Altoè; Alessio Vieno; Alessandra Simonelli; Gabriele Caselli; Marcantonio M Spada
Journal:  J Behav Addict       Date:  2019-03-31       Impact factor: 6.756

6.  Metacognitive Therapy for Individuals at High Risk of Developing Psychosis: A Pilot Study.

Authors:  Sophie Kate Parker; Lee D Mulligan; Philip Milner; Samantha Bowe; Jasper E Palmier-Claus
Journal:  Front Psychol       Date:  2020-01-17

7.  The path from schizotypy to depression and aggression and the role of family stress.

Authors:  Preethi Premkumar; Elizabeth Kuipers; Veena Kumari
Journal:  Eur Psychiatry       Date:  2020-07-30       Impact factor: 5.361

8.  Testing measurement invariance of the schizotypal personality questionnaire-brief scores across Spanish and Swiss adolescents.

Authors:  Javier Ortuño-Sierra; Deborah Badoud; Francesca Knecht; Mercedes Paino; Stephan Eliez; Eduardo Fonseca-Pedrero; Martin Debbané
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.